Nancy Hong serves as Principal at BioMed Ventures. She joined BioMed Ventures in April 2013. Previously she was a senior analyst at Forward Ventures and advised biotech and pharma companies, including the Genomics Institute of the Novartis Research Foundation, entering new areas of research. From 2002 to 2006 Dr. Hong was a senior scientist at Phenomix where she directed a scientific group, managed pharma collaborations, and evaluated research opportunities. Dr. Hong trained in the areas of immunology and oncology, and she was a postdoctoral fellow of The Leukemia & Lymphoma Society with Nobel-laureate Dr. J. Michael Bishop at the University of California, San Francisco. Dr. Hong received a Bachelor of Science with honors in biology from the California Institute of Technology and a Ph.D. in Molecular and Cellular Biology from the University of California at Berkeley.


Education:
California Institute of Technology, BS (Bachelor of Science), Biology
University of California, Berkeley, Ph.D. (Doctor of Philosophy), Molecular and Cellular Biology